tweetindex
ES

Intellia Therapeutics ✓

@intelliatx · Cambridge, MA · joined 31 Jul 2014

We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: https://t.co/u2gHl9Tmgr

12 245Followers
204Following
1 143Posts total
21.1KViews on collected posts

Últimas publicaciones

Pleased to share that Intellia Vice President of Pharmacology & Toxicology Jonathan Phillips will be delivering an invited talk this week at the Charles River (@CRiverLabs) Biotech Symposium in San Diego, CA. https://t.co/V3tVXwWntf
1K views · 23 likes · 3 reposts · 1 replies Open on X →
@intelliatx @US_FDA And the stock falls another 4%. 🚀 70 views · 0 likes · 0 reposts · 0 replies Open on X →
@intelliatx @anexpertone @US_FDA https://t.co/kbvKUtfI1W
GIF
91 views · 1 likes · 0 reposts · 0 replies Open on X →
@intelliatx Great execution 👏 Time to cure HAE. 264 views · 3 likes · 0 reposts · 0 replies Open on X →
📢 $NTLA News: And so the countdown begins... We are proud to share the @US_FDA has accepted Intellia's Biologics License Application (BLA) with Priority Review for our potential one-time #hereditaryangioedema treatment. The PDUFA target action date is March 10, 2027. Read the h
0:16
14.9K views · 124 likes · 30 reposts · 5 replies Open on X →
Intellia will participate in a fireside chat at the @MorganStanley 24th Annual Global Healthcare Conference in NYC on September 14. We look forward to the insightful conversations and sharing about our continued progress. Full details here: https://t.co/zlCoJidKhs $NTLA https://t
1.6K views · 14 likes · 3 reposts · 0 replies Open on X →
Intellia will present at the upcoming Bradykinin Symposium, taking place Sept. 3-4 in Berlin, Germany. HCPs: Stop by our booth for a look at our educational materials on all things Intellia. https://t.co/PDCak5K25z
1.6K views · 22 likes · 4 reposts · 0 replies Open on X →
We're pleased to be named a 2026 Fierce 50 honoree in the Breakthrough category. This distinction reflects Intellia's continued progress in #geneediting and our team's commitment to developing novel therapies for life threatening conditions. Congrats to all who made the list! htt
0:17
1.6K views · 23 likes · 5 reposts · 0 replies Open on X →

Frente a cuentas del mismo tamaño

8 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. llega a mucha gente, pero pocos de esos espectadores reaccionan.

Visualizaciones medianas1 294esta cuenta924mediana de 10K–100K
Alcance, %10.56%esta cuenta3.62%mediana de 10K–100K
Interacción, %1.13%esta cuenta1.52%mediana de 10K–100K
MétricaEsta cuentaMediana de 10K–100KProporción
Visualizaciones medianas por publicación1 2949241.40×
Alcance (visualizaciones ÷ seguidores)10.56%3.62%2.92×
Tasa de interacción1.13%1.52%0.74×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.6K1 Sep
1.6K2 Sep
1.6K4 Sep
14.9K8 Sep
264
91
70
1K15 Sep

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.76%1 Sep
1.72%2 Sep
1.12%4 Sep
1.11%8 Sep
1.14%
1.10%
0.00%
2.66%15 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes75.3%210 in total
Reposts16.1%45 in total
Replies2.2%6 in total
Quotes3.2%9 in total
Bookmarks3.2%9 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares